Amanda Maul

Person

Mentions

Episodes

Claims

Amanda Maul, mentioned 6 times across podcast episodes and expert conversations analyzed by Sonic.

What Amanda Maul has said

The list price for most GLP-1 drugs, such as Ozempic and Wegovy, is more than $1,000 per month.

neutral·Amanda Maul

The biological mechanism of the peptide BPC-157 suggests a potential risk of accelerating the growth of existing tumors.

bearish·Amanda Maul

Robert F. Kennedy Jr. has directed the FDA to reconsider the regulatory status of several peptides that the Biden administration had previously placed on a banned list.

bullish·Amanda Maul

The list price for most GLP-1 drugs, such as Ozempic and Wegovy, is more than $1,000 per month.

Expert perspectiveAmanda MaulJun 19

The biological mechanism of the peptide BPC-157 suggests a potential risk of accelerating the growth of existing tumors.

SpeculativeAmanda MaulJun 19

Robert F. Kennedy Jr. has directed the FDA to reconsider the regulatory status of several peptides that the Biden administration had previously placed on a banned list.

Expert perspectiveAmanda MaulJun 19

Some telehealth companies are legally selling compounded versions of GLP-1 drugs for approximately $250 to $300 per month.

Expert perspectiveAmanda MaulJun 19

In 2023, the Biden administration placed nearly 20 popular peptide compounds on the Category 2 list, restricting their use by compounding pharmacies.

Expert perspectiveAmanda MaulJun 19

The U.S. Food and Drug Administration's current position is that the sale of many popular gray market peptides is illegal.

Expert perspectiveAmanda MaulJun 19

Create a free account to see Amanda Maul's full intelligence report - every claim, the relationship network, and AI Q&A across all sources. No card needed.

Get started free

Back to Entities Entity Detail